Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy

Cancer immunotherapy is impaired by the intrinsic and adaptive immune resistance. Herein, a bispecific prodrug nanoparticle was engineered for circumventing immune evasion of the tumor cells by targeting multiple immune resistance mechanisms. A disulfide bond-linked bispecific prodrug of NLG919 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jiayi, Hou, Bo, Chen, Fangmin, Zhang, Shunan, Xiong, Muya, Li, Tianliang, Xu, Yechun, Xu, Zhiai, Yu, Haijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214055/
https://www.ncbi.nlm.nih.gov/pubmed/35755274
http://dx.doi.org/10.1016/j.apsb.2021.09.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214055/
https://www.ncbi.nlm.nih.gov/pubmed/35755274
http://dx.doi.org/10.1016/j.apsb.2021.09.021

Ejemplares similares